Ricardo Zayas
Corporate Officer/Principal presso CATALENT, INC.
Patrimonio netto: 334 735 $ in data 31/05/2024
Profilo
Ricardo Zayas is currently the Senior VP-North America Biologic Operations at Catalent, Inc. He previously worked as the Vice President & General Manager-Operations at Wyeth Pharmaceuticals LLC from 2007 to 2009, Senior Vice President-Operations at AMAG Pharmaceuticals, Inc. from 2009 to 2011, and General Manager-Operations at Schering-Plough Pharmaceuticals from 2001 to 2007.
He also held positions as the Chief Operations Officer at Romark Global Pharma LLC and Chief Operating Officer & Operational Lead at OcyonBio.
Mr. Zayas received his undergraduate degree from Kansas State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CATALENT INC
0.00% | 01/08/2023 | 6 223 ( 0.00% ) | 334 735 $ | 31/05/2024 |
Posizioni attive di Ricardo Zayas
| Società | Posizione | Inizio |
|---|---|---|
| CATALENT, INC. | Corporate Officer/Principal | 17/01/2023 |
Precedenti posizioni note di Ricardo Zayas
| Società | Posizione | Fine |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Direttore operativo | 11/02/2011 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | 02/01/2009 |
| Schering-Plough Pharmaceuticals | Corporate Officer/Principal | 02/01/2007 |
| Ocyonbio | Direttore operativo | - |
Romark Global Pharma LLC
 Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Direttore operativo | - |
Formazione di Ricardo Zayas
| Kansas State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CATALENT, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| Schering-Plough Pharmaceuticals | |
Romark Global Pharma LLC
Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Health Technology |
| Ocyonbio |
- Borsa valori
- Insiders
- Ricardo Zayas
